Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Sean J. Barbour

ResearcherPublications, citations & collaboration network

Sean J. Barbour is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 86 works, 4,461 citations, an h-index of 33 and an i10-index of 54.

86
Works
4,461
Citations
33
h-index
54
i10-index

How has Sean J. Barbour's publication output changed over time?

ScholarIQpublication output · 2011–2024

Output grew0% over the shown period — from 1 works in 2011 to 1 in 2024.

1
1
2
1
4
1
1
1
20112012201320152019202020232024

What are the most-cited papers on Sean J. Barbour?

ScholarIQmost cited works
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
Fernando C. Fervenza, Gerald B. Appel, Sean J. Barbour, Brad H. Rovin, Richard Lafayette, Nabeel Aslam, Jonathan Ashley Jefferson, Patrick E. Gipson, Dana V. Rizk, John R. Sedor, James F. Simon, Ellen T. McCarthy, Paul Brenchley, Sanjeev Sethi, Carmen Ávila-Casado, Heather Beanlands, John C. Lieske, David Philibert, Tingting Li, Leslie F. Thomas, Dolly F. Green, Luis A. Juncos, Lada Beara‐Lasić, Samuel S. Blumenthal, Amy N. Sussman, Stephen B. Erickson, Michelle Hladunewich, Pietro A. Canetta, Lee A. Hebert, Nelson Leung, Jay Radhakrishnan, Heather N. Reich, Samir V. Parikh, Debbie S. Gipson, Dominic K. Lee, Bruno R. da Costa, Peter Jüni, Daniel Cattran
New England Journal of Medicine. 2019605 CitationsOPEN ACCESS
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy
Sean J. Barbour, Rosanna Coppo, Hong Zhang, Zhi-Hong Liu, Yusuke Suzuki, Keiichi Matsuzaki, Ritsuko Katafuchi, Lee Er, Gabriela Espino-Hernández, S. Joseph Kim, Heather N. Reich, John Feehally, Daniel Cattran, International IgA Nephropathy Network
JAMA Internal Medicine. 2019485 CitationsOPEN ACCESS
The MEST score provides earlier risk prediction in lgA nephropathy
Sean J. Barbour, Gabriela Espino-Hernández, Heather N. Reich, Rosanna Coppo, Ian S.D. Roberts, John Feehally, Andrew M. Herzenberg, Daniel C. Cattran, Nüket Bavbek, Terry Cook, S. Troyanov, Charles E. Alpers, Alfonso Amore, Jonathan Barratt, F. Berthoux, Stephen M. Bonsib, Jan A. Bruijn, Vivette D. D’Agati, Giuseppe D’Amico, Steven N. Emancipator, F. Emmal, Franco Ferrario, Fernando C. Fervenza, Sandrine Florquin, Agnes B. Fogo, Colin Geddes, Hermann-Josef Groene, Mark Haas, P. Hill, Ronald J. Hogg, Stephen I‐Hong Hsu, Tracy E. Hunley, Michelle Hladunewich, Caroline E. Jennette, Kensuke Joh, Bruce A. Julian, Takeshi Kawamura, F M Lai, Chi Bon Leung, L. Li, P. Li, Zhihong Liu, A. Massat, Bruce Mackinnon, Sergio Mezzano, Francesco Paolo Schena, Yasuhiko Tomino, Patrick D. Walker, H. Wang, Jan J. Weening, Nori Yoshikawa, H. Zhang, Rosanna Coppo, S. Troyanov, Daniel C. Cattran, H. Terence Cook, John Feehally, Ian S.D. Roberts, Vladimı́r Tesař, Dita Maixnerová, Sigrid Lundberg, Loreto Gesualdo, Francesco Emma, Laura Fuiano, G. Beltrame, Cristiana Rollino, Rc, Alfonso Amore, Roberta Camilla, Licia Peruzzi, Manuel Praga, Sandro Feriozzi, Rosaria Polci, Giuseppe Segoloni, Loredana Colla, Antonello Pani, Andrea Angioi, Lisa Adele Piras, JF JF, Giovanni Cancarini, S. Ravera, Magdalena Durlik, Elisabetta Moggia, José Ballarín, S. Di Giulio, Francesco Pugliese, I. Serriello, Y. Caliskan, Mehmet Şükrü Sever, İşın Kiliçaslan, Francesco Locatelli, Lucia Del Vecchio, Jack F.M. Wetzels, Harm Peters, U. Berg, Fernanda Carvalho, A.C. da Costa Ferreira, M. Maggio, Andrzej Więcek, Mai Ots-Rosenberg
Kidney International. 2015297 CitationsOPEN ACCESS
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
David Z.I. Cherney, Claire C. J. Dekkers, Sean J. Barbour, Daniel C. Cattran, Abdul Halim Abdul Gafor, Peter J. Greasley, Gozewijn D. Laverman, Soo Kun Lim, Gian Luca Di Tanna, Heather N. Reich, Marc Vervloet, Muh Geot Wong, Ron T. Gansevoort, Hiddo J.L. Heerspink
The Lancet Diabetes & Endocrinology. 2020277 CitationsOPEN ACCESS
Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis
Sean J. Barbour, Allen Greenwald, Ognjenka Djurdjev, Adeera Levin, Michelle Hladunewich, Patrick H. Nachman, Susan L. Hogan, Daniel C. Cattran, Heather N. Reich
Kidney International. 2011209 Citations

Related on ScholarIQ

Provincial Health Services Authority
Institution
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
Paper
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy
Paper
The MEST score provides earlier risk prediction in lgA nephropathy
Paper
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
Paper
Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis
Paper
470M+ articles · free account